Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01627210 · ClinicalTrials.gov registry record
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 60
- Enrollment target
NCT01627210 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 60 participants.
The verdict
NCT01627210 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized, observational study conducted in the United States.Up to sixty (60) subjects will be enrolled. The purpose of the study is to evaluate long-term utility and usability of Dexcom G4 Continuous Glucose Monitoring (CGM) System. Subjects will be followed monthly over a period of one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01627210
The ClinicalTrials.gov registry entry for NCT01627210 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01627210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01627210 about?
NCT01627210 is a clinical study titled "Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System". This is a prospective, non-randomized, observational study conducted in the United States.Up to sixty (60) subjects will be enrolled. The purpose of the study is to evaluate long-term utility and usability of Dexcom G4 Continuous Glucose Monitoring (CGM) System. Subjects will be followed monthly ove...
What is the current status of trial NCT01627210?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-05. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01627210?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.